Why Most Antimicrobial Data Fails at Translation
February 2026 // Platform Thinking // R&D Strategy
In antimicrobial R&D, we're often drowning in data but starving for actionable evidence. We celebrate "hits" in the lab—zones of inhibition, promising MICs—then watch them evaporate when exposed to the biophysics of real membranes, the kinetics of real protein binding, and the ecology of real infections.
